Oligonucleotide Synthesis Market Size Worth USD 12.49 Billion By 2034| CAGR: 15.01%
The global oligonucleotide synthesis market size is exapected to reach USD 12.49 billion by 2034, according to a new study by Polaris Market Research. The report “Oligonucleotide Synthesis Market Share, Size, Trends, Industry Analysis Report, By Product (Synthesized Oligonucleotide Products, Equipment, Reagents, Equipment, and Services); By Application; By Region; Segment Forecast, 2026- 2034” gives a dsetailed insight into current market dynamics and provides analysis on future market growth.
Oligonucleotide synthesis is the process of making short DNA or RNA sequences. These sequences are used in PCR, sequencing, genetic testing, molecular diagnostics, gene expression studies, drug discovery, and gene editing. They are also used to develop nucleic acid-based medicines.
The oligonucleotide synthesis market is driven by an increasing demand for custom DNA and RNA sequences. Increasing research in genetics, diagnostics and new therapies is creating opportunities for the growth of the oligonucleotide synthesis market.
Key Market Highlights
- The global oligonucleotide synthesis market was valued at USD 3.55 billion in 2025 and is expected to reach USD 12.49 billion by 2034.
- The market is projected to grow at a CAGR of 15.01% from 2026 to 2034, supported by rising demand for customized DNA and RNA sequences.
- The growing use of oligonucleotide-based medicines, including antisense oligonucleotides and siRNA therapies, is creating new market opportunities.
- Molecular diagnostics, PCR, sequencing, and genetic research continue to support demand for oligonucleotide products and services.
- North America held an 40.9% share of the global oligonucleotide synthesis market in 2025, supported by strong pharmaceutical, biotechnology, and research activity.
- From 2026 to 2034 Asia Pacific is expected to register a CAGR of 17.5%, making it the fastest-growing regional market.
Growing Demand for Oligonucleotide-Based Medicines Supports Market Growth
The growing development of oligonucleotide-based medicines is creating new demand for synthesis products and services. Antisense oligonucleotides are used to regulate gene expression, while siRNA therapies work by silencing specific genes linked to disease. These approaches are being explored across rare diseases, cancer, cardiovascular disease and other therapeutic areas.
The rise of targeted genetic applications is also increasing the need for customized DNA and RNA sequences. To improve stability, delivery, or activity RNA therapeutics and disease research often require specific sequences with chemical modifications. As development programs advance, companies also need reliable manufacturing, purification, analytical testing, and scale-up capabilities to support research and commercial production.
Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Oligonucleotide Synthesis Market Report
Molecular Diagnostics and Research Expand Oligonucleotide Applications
In molecular diagnostics and life science research oligonucleotides play an important role. PCR primers and probes are widely used to identify and study specific genetic targets. Sequencing and genotyping also depend on oligonucleotides to examine DNA variations and genetic information.
Growing use of gene expression analysis, DNA microarrays, and molecular diagnostics is creating further demand. For infectious disease detection and cancer biomarker research oligonucleotides are also used. At the same time, expanding genomics and genetic testing is increasing the need for customized sequences across research and diagnostic applications.
Automation and Advanced Synthesis Improve Manufacturing
Automation is improving the speed and consistency of oligonucleotide production. Automated synthesis systems support high-throughput production and help manufacturers handle larger numbers of sequences. As production scales better purification and quality-control processes also help maintain product quality.
For advanced manufacturing methods the development of longer oligonucleotide sequences and chemically modified sequences is creating demand. Enzymatic synthesis is also gaining attention as an alternative approach. The production, purification and testing of complex oligonucleotides can be made more efficient through advanced synthesis and analytical technologies.
Regional Market Outlook for Oligonucleotide Synthesis
North America remains a major market for oligonucleotide synthesis, supported by its strong pharmaceutical and biotechnology industry and advanced research infrastructure. In 2025 the region accounted for an 40.9% share of the global market. High demand for molecular biology products and services is also supporting growth. For oligonucleotide synthesis providers increasing research in RNA therapeutics, gene editing, and molecular diagnostics is creating further opportunities.
Asia Pacific is expected to register a CAGR of 17.5% during the forecast period. Rising investments in biotechnology, genomics, and personalized medicine are supporting market growth across the region. Segments such as molecular diagnostics, genetic testing and biopharmaceutical development are seeing heightened activity in China, Japan and India. For customized oligonucleotide products and services growing research capabilities and healthcare investments are also creating new demand.
Europe is an important regional market, supported by pharmaceutical research, biotechnology activity, and growing interest in advanced therapies. The Latin America region is expected to see gradual growth due to better health care and diagnostic infrastructure. Growing healthcare systems, pharmaceutical research and biotechnology activity are also providing opportunities in the Middle East & Africa region.
Companies Expand Custom and Therapeutic Oligonucleotide Capabilities
The competitive landscape includes large life science companies and specialized synthesis providers serving pharmaceutical and biotechnology customers. Companies are expanding synthesis capacity, purification, analytical testing, and manufacturing capabilities to support research and therapeutic applications.
Major companies operating in the market include Agilent Technologies, Inc., Ansa Biotechnologies, ATDBio Ltd., Azenta Life Sciences (GENEWIZ), Bio-Synthesis, Inc., Eurofins Genomics, GenScript Biotech Corporation, Integrated DNA Technologies (IDT), LGC Biosearch Technologies, Merck KGaA, Nitto Denko Avecia Inc., Thermo Fisher Scientific Inc., TriLink BioTechnologies, and Twist Bioscience Corporation.
Future Market Outlook
The future of the oligonucleotide synthesis market is expected to be supported by growing demand for RNA therapeutics, gene editing, personalized medicine, and molecular diagnostics. Advances in genetic research are also increasing the need for customized sequences for research and therapeutic applications.
Automation and high-throughput manufacturing can improve production speed and consistency. Enzymatic synthesis may support the production of longer and more complex oligonucleotides. Improvements in purification and quality control can further support manufacturing. Advances in sequence design are also expected to help develop more specialized oligonucleotides for emerging applications.
Polaris Market Research has segmented the oligonucleotide synthesis market report based on product, application, and region:
| Market Segmentation | Subsegments |
| By Product | Synthesized Oligonucleotide Products; Equipment; Reagents; Services |
| By Application | PCR Assays and Panels; PCR Primers; DNA Microarrays; Sequencing; Antisense Oligonucleotides; FISH; Others |
| By End User | Pharmaceutical & Biotechnology Companies; Academic & Research Institutes; Diagnostic Laboratories; CROs; Hospitals & Clinical Laboratories |
| By Technology/Chemistry | Phosphoramidite Chemistry; Solid-Phase Synthesis; Liquid-Phase Synthesis; Enzymatic Synthesis; Other Advanced Synthesis Technologies |
| By Region | North America: U.S., Canada; Europe: France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe; Asia Pacific: Japan, China, India, Malaysia, Indonesia, South Korea, Australia, Rest of APAC; Latin America: Brazil, Mexico, Argentina, Rest of LA; Middle East & Africa: Saudi Arabia, UAE, Israel, South Africa, Rest of MEA |
